ÂÜÀòÂÒÂ×

Dan Edelstein is an experienced leader in the biotechnology and diagnostics sectors, currently serving as General Manager at Quest Diagnostics and Chief Executive Officer at Haystack Oncology since July 2021. Previously, Dan held several roles at Sysmex Inostics, including SVP of Commercial Operations and COO, where responsibilities included leading reimbursement strategies and managing clinical studies. Dan's career also includes a significant role at Inostics, Inc. as Vice President of Operations, where oversight on CLIA laboratory certification for a pioneering liquid biopsy technology was achieved. Academic credentials include a Master's in Biotechnology and an MBA from The Johns Hopkins University, as well as a Bachelor's in Environmental Science and Chemistry from Virginia Tech.